X-133026081-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031907.3(USP26):c.2140A>T(p.Ile714Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 111,151 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_031907.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP26 | NM_031907.3 | c.2140A>T | p.Ile714Phe | missense_variant | 6/6 | ENST00000511190.6 | NP_114113.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USP26 | ENST00000511190.6 | c.2140A>T | p.Ile714Phe | missense_variant | 6/6 | 2 | NM_031907.3 | ENSP00000423390.1 | ||
USP26 | ENST00000370832.1 | c.2140A>T | p.Ile714Phe | missense_variant | 1/1 | 6 | ENSP00000359869.1 |
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111151Hom.: 0 Cov.: 21 AF XY: 0.0000300 AC XY: 1AN XY: 33323
GnomAD3 exomes AF: 0.00000548 AC: 1AN: 182349Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67525
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111151Hom.: 0 Cov.: 21 AF XY: 0.0000300 AC XY: 1AN XY: 33323
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 10, 2024 | The c.2140A>T (p.I714F) alteration is located in exon 1 (coding exon 1) of the USP26 gene. This alteration results from a A to T substitution at nucleotide position 2140, causing the isoleucine (I) at amino acid position 714 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at